Editas Medicine, Inc.
EDIT
$2.82
$0.010.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.03% | -344.52% | 77.62% | 52.82% | 30.03% |
| Total Depreciation and Amortization | -13.87% | -40.00% | 11.65% | -60.69% | -4.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.78% | 100.30% | -64.07% | -21.42% | -33.66% |
| Change in Net Operating Assets | -703.95% | 94.44% | -201.60% | -138.35% | -126.23% |
| Cash from Operations | -28.22% | 36.62% | -17.97% | 38.57% | -5.05% |
| Capital Expenditure | -15.22% | -53.33% | 86.14% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -100.00% | 32.20% | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -5.87% | -24.78% |
| Cash from Investing | -46,662.50% | 10.34% | -99.85% | -7.21% | -24.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.91% | 131.64% | 416.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -- | -- | 0.91% | 131.64% | 615.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 352.93% | -21.02% | -173.37% | 17,366.00% | -102.10% |